Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

0 avis

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

Archive ouverte

Edité par CCSD ; Oxford University Press -

International audience. Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

Archive ouverte | Monel, Blandine | CCSD

International audience. BackgroundThe dynamics of SARS-CoV-2 alpha variant shedding and immune responses at the nasal mucosa remain poorly characterised.MethodsWe measured infectious viral release, antibodies and cy...

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Archive ouverte | Planas, Delphine | CCSD

International audience. The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1,2,3,4,5. Since then, it has become dominant in some regions of India and in the UK, and has spread to many other countr...

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Archive ouverte | Planas, Delphine | CCSD

International audience. The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1-3. It has since spread to many countries and is expected to rapidly become dominant worldwid...

Chargement des enrichissements...